TELIX Pharmaceuticals Ltd (TLX) — Free Cash Flow Generation Index
TELIX Pharmaceuticals Ltd (TLX) has a Free Cash Flow Generation Index of 0.60x as of June 2025. Free cash flow of AU$16.84 Million represents 1% of operating cash flow (AU$27.98 Million). Read total liabilities of TELIX Pharmaceuticals Ltd for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
TELIX Pharmaceuticals Ltd Free Cash Flow Generation Index (2020–2024)
Historical FCF Generation Index trend for TELIX Pharmaceuticals Ltd across 3 annual periods. Explore capital reinvestment ratio of TELIX Pharmaceuticals Ltd to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for TELIX Pharmaceuticals Ltd (2020–2024)
Year-by-year Free Cash Flow Generation Index for TELIX Pharmaceuticals Ltd. For the full company profile including market capitalisation, see market value of TELIX Pharmaceuticals Ltd.
| Year | FCG Index | Free Cash Flow (AUD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.21x | AU$9.00 Million | AU$43.03 Million | AU$34.03 Million | ▼ -61.8% |
| 2023 | 0.55x | AU$13.09 Million | AU$23.88 Million | AU$10.79 Million | ▼ -34.4% |
| 2020 | 0.84x | AU$1.64 Million | AU$1.96 Million | AU$322.00K | — |